Log In
Print
BCIQ
Print
Print this Print this
 

Opicapone (BIA 9-1067)

  Manage Alerts
Collapse Summary General Information
Company Bial-Portela & Ca. S.A.
DescriptionCatechol-O-methyl-transferase (COMT) inhibitor
Molecular Target Catechol-O-methyl-transferase (COMT)
Mechanism of ActionCatechol-O-methyl-transferase (COMT) inhibitor
Therapeutic Modality 
Latest Stage of DevelopmentPhase III
Standard IndicationParkinson's disease (PD)
Indication DetailsTreat Parkinson's disease (PD)
Regulatory Designation

Partner

Ono Pharmaceutical Co. Ltd.


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today